health
Blood Potassium Decrease
Adverse effectBlood Potassium Decrease is an adverse health effect in which the amount of potassium in the blood becomes lower. It is also described as hypokalemia; one reported threshold is potassium <3.5 mmol/l.
Blood Potassium Decrease is listed as a health effect for focused review.
These are research findings, not promises. Most options have little evidence, and results differ from person to person.
What can cause it
How likely each one is to cause it, most likely first.
FastingpracticeUnclear
Based on one study. Strongest study: a pooled analysis of several trials.
A pooled analysis whose study designs were not recorded reported low potassium. The finding does not quantify the change.
Open the Fasting pageFinnish SaunapracticeUnclear
Based on one study. Strongest study: a study that followed people over time.
A 1986 cohort study involving 10 people recorded decreases in serum potassium, sodium, and iron.
Open the Finnish Sauna pageCoffee EnemapracticeUnclear
Based on one study.
Repeated or excessive Coffee Enema use has been associated with potassium depletion, including severe hypokalemia.
Open the Coffee Enema page
The expert view shows every study, dose protocol and source.
What can cause it
Interventions reported to bring this on3 listedHighest probability
- →PracticesFastingCertaintyLowSourceClinical1 other source
A pooled analysis whose study designs were not recorded reported low potassium. The finding does not quantify the change.
- →PracticesFinnish SaunaCertaintyLowSourceClinical1 other source
A 1986 cohort study involving 10 people recorded decreases in serum potassium, sodium, and iron.
Who was studied
- Healthy people
Open Finnish SaunaStudy result
Decrease in serum potassium, sodium and iron
- →PracticesCoffee EnemaCertaintyLowSourceReference knowledge1 other source
Repeated or excessive Coffee Enema use has been associated with potassium depletion, including severe hypokalemia.
Open Coffee EnemaStudy result
Repeated or excessive coffee enemas have been associated with clinically significant potassium depletion, including severe hypokalemia.
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Blood Potassium Decrease is an adverse health effect in which the amount of potassium in the blood becomes lower. It is also described as hypokalemia; one reported threshold is potassium <3.5 mmol/l. This refers specifically to a change in blood potassium, rather than to potassium intake or potassium stored elsewhere in the body.
How interventions help
The substances associated with this outcome are linked to lower blood potassium, not to a beneficial intervention designed to produce that change. The pathways described fall into several broad patterns: increased potassium loss through the kidneys, loss of electrolytes related to laxative effects, movement of potassium from the blood into cells, and increased potassium use during rapid production of red blood cells.
Some associations involve more than one pathway. For example, stimulant-related effects may combine increased urinary loss with a shift of potassium into cells, while repeated laxative or enema use may deplete potassium through gastrointestinal losses. Kidney-related potassium wasting may become more relevant when another diuretic is used at the same time.
The clinical findings include reductions in measured serum potassium, including hypokalemia. The evidence does not establish one shared dose, duration, onset, or persistence after stopping across these substances; the circumstances differ between them. Several findings also concern particular situations, such as intensive early replacement in severe megaloblastic anemia or repeated and excessive use, so they should not automatically be generalized to every use pattern.
Because low potassium can reflect different underlying processes, interpreting these associations requires attention to concurrent medicines, the type of exposure, and the setting in which the change occurred. The health status of the people studied was not specified, limiting conclusions about which populations these findings apply to.
Choosing guidance
When choosing among these options, first consider whether the concern is a direct clinical finding or a risk described in pharmacology references. Sodium Bicarbonate, Lemon Balm (Melissa), Vitamin C, Quercetin, and Aloe Vera have clinical evidence, whereas Apple Cider Vinegar, Caffeine, Green Tea Extract (EGCG), Vitamin B12 (Cobalamin), and Coffee Enema are described through pharmacology references. This distinction matters because the latter group may be less suitable when decisions require evidence from studies in people.
The reported explanations fall into different patterns. Some involve electrolyte loss, including laxative-related losses with Aloe Vera and repeated or excessive Coffee Enema use. Others involve intracellular potassium shifts or urinary losses, including the descriptions associated with Caffeine and Green Tea Extract (EGCG). Apple Cider Vinegar is specifically discussed in the context of chronic high-dose use, while Vitamin B12 (Cobalamin) is linked to intensive early replacement in high-risk situations. These descriptions should not be treated as interchangeable.
The available information does not establish a common dose, duration of use, or time to onset across the options, so it cannot identify which choice acts fastest or compare how much exposure is required. It also does not specify the health status of the people studied. Readers with a condition affecting potassium balance, those using diuretics, or those considering intensive treatment should not assume that findings from one option apply to another.